Primary gout
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. aged 18-60 years old; 2. Serum uric acid value: male > 420 micromol/L; female > 360 micromol/L; 3. Has a history of gout attacks, and conforms to the diagnostic criteria for acute gouty arthritis established by the American Rheumatological Society (ACR) in 2012; 4. The course of gout was more than 1 year, and the number of acute attacks was more than 2 times in the past 1 year; 5. Subject's consent and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who do not meet the above inclusion criteria; 2. Secondary hyperuricemia; 3. The drugs affecting blood uric acid could not be stopped; 4. Late gouty arthritis with severe kidney stones and joint deformations; 5. For the past two weeks, the patients treated with allopurinol and benzbromarone were treated with hypouric acid/antigout drugs; 6. Hormone drugs were used within 6 months; 7. Overlapping other rheumatic diseases such as rheumatoid arthritis, systemic lupus erythematosus, Sjogren's syndrome and severe knee osteoarthritis; 8. Patients with serious diseases such as heart, brain, liver, kidney and hematopoietic system; 9. Pregnant or lactating women, psychiatric patients, etc.; 10. Those with severe bone destruction and severe impairment of limb function; 11. pairs of drug allergic patients; 12. Those who have participated in similar clinical trials in 121 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum uric acid; | — |
Secondary
| Measure | Time frame |
|---|---|
| ESR;CRP;TCHO;TG;HDL-C;LDL-G;GLU;Scoring of local symptoms and signs of joints;Quantitative evaluation of TCM symptom classification; | — |
Countries
China
Contacts
Guangzhou Hongyun Medical Scientific and Technological Co.,Ltd.